Michael H. Carrel - 30 Jun 2026 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Reporting relationship: President, CEO, & Director, Director
Issuer ticker: ATRC
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 09:06:31 UTC
Prior SEC filing: 09 Mar 2026
Next SEC filing: 27 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Allison Walker as Attorney-in-fact for Michael H. Carrel

Key filing fact

Michael H. Carrel filed Form 4 for AtriCure, Inc. (ATRC) on 02 Jul 2026.

Key facts

This page summarizes Michael H. Carrel's Form 4 filing for AtriCure, Inc. (ATRC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 09:06.

Change

Previous filing in this sequence was filed on 09 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001230584 Primary reporting owner

CARREL MICHAEL H

Relationship: President, CEO, & Director, Director
Address: 7555 INNOVATION WAY, MASON
Signature: /s/ Allison Walker as Attorney-in-fact for Michael H. Carrel
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATRC transaction

Common Stock

Award

Transaction value
Shares: +636
Change %: +0.08%
Price: $23.78^*
Shares after: 779,134
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1, F2

ATRC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14,310
Date: 30 Jun 2026
Ownership: Held by reporting person's children
Footnotes: F3

ATRC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,250
Date: 30 Jun 2026
Ownership: Held by reporting person's parents
Footnotes: F3

ATRC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,000
Date: 30 Jun 2026
Ownership: Held by reporting person's sibling
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

Footnote F2

In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

Footnote F3

The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.